PuSH - Publication Server of Helmholtz Zentrum München: Next-generation dendritic cell vaccination as postremission therapy for AML patients with a non-favorable risk profile.

Navigation

Research

Browse by ...

... Journal

Support & Contact

Lichtenegger, F.S. ; Schnorfeil, F.M. ; Altmann, T.* ; Köhnke, T.* ; Buecklein, V.* ; Geiger, C. ; Wagner, B.* ; Henschler, R.* ; Bigalke, I. ; Kvalheim, G.* ; Hiddemann, W.* ; Schendel, D.J. ; Subklewe, M.*

Next-generation dendritic cell vaccination as postremission therapy for AML patients with a non-favorable risk profile.

Oncol. Res. Treat. 37, 310 (2014)

Open Access Green as soon as Postprint is submitted to ZB.

Additional Metrics?

Edit extra informations Login

Publication type Article: Journal article

Document type Meeting abstract

ISSN (print) / ISBN 2296-5270

e-ISSN 2296-5262

Quellenangaben Volume: 37, Pages: 310

Publisher Karger

Reviewing status Peer reviewed

Institute(s) Institute of Molecular Immunology (IMI)
CCG Hematopoetic Cell Transplants (IMI-KHZ)